---
name: Copy Glenview Capital
kind: hedgecopy-fund
cik: 0001138995
latest_13f_period: 2026-06-30
latest_13f_filed: 2026-08-14
author: HedgeCopy
---

# Copy Glenview Capital (13F follow-the-filing)

Glenview Capital files a 13F-HR with the SEC each quarter (CIK 0001138995). This skill describes a
long-only copy portfolio built from that filing, bought the trading day after it is filed.

## Track record (estimated from 13F holdings, net of 10 bps per unit of turnover)
- Annualised return copying the filings, last 3 years (headline): +16.8% vs SPY +22.9% (alpha -6.1%/yr)
- Annualised since the series started (2022-08-19 to 2026-10-09): +11.6% vs SPY +17.3%
- Follow-the-filing TTM: +20.0% vs SPY +16.2% (alpha +3.8%)
- Quarters of history: 17; average coverage 73%; flags: low_coverage

## Latest disclosed top holdings (2026-06-30)
| # | Ticker | Issuer | Weight |
|---|---|---|---|
| 1 | GPN | GLOBAL PMTS INC | 12.9% |
| 2 | CVS | CVS HEALTH CORP | 10.0% |
| 3 | THC | TENET HEALTHCARE CORP | 8.4% |
| 4 | TMO | THERMO FISHER SCIENTIFIC INC | 6.3% |
| 5 | AMZN | AMAZON COM INC | 6.1% |
| 6 | A | AGILENT TECHNOLOGIES INC | 5.2% |
| 7 | DHR | DANAHER CORP DEL | 4.4% |
| 8 | META | META PLATFORMS INC | 4.0% |
| 9 | AMD | ADVANCED MICRO DEVICES INC | 3.5% |
| 10 | — | TEVA PHARMACEUTICAL INDS LTD | 3.4% |
| 11 | VTRS | VIATRIS INC | 3.1% |
| 12 | UBER | UBER TECHNOLOGIES INC | 2.6% |
| 13 | CNC | CENTENE CORP DEL | 2.4% |
| 14 | BFLY | BUTTERFLY NETWORK INC | 2.4% |
| 15 | CI | THE CIGNA GROUP | 2.3% |
| 16 | HUM | HUMANA INC | 2.0% |
| 17 | XYZ | BLOCK INC | 1.8% |
| 18 | DKS | DICKS SPORTING GOODS INC | 1.8% |
| 19 | — | GENIUS SPORTS LIMITED | 1.6% |
| 20 | ONTO | ONTO INNOVATION INC | 1.6% |

## About the fund

Glenview Capital Management is a New York-based, privately held investment management firm founded in 2000 by Larry Robbins. The firm manages capital for qualified investors through a series of private investment funds, employing fundamental research and individual security selection across long/short equity and opportunistic strategies.

- Strategy: Long/short equity, opportunistic, and healthcare-focused strategies using a GARP (Growth at a Reasonable Price) approach.
- Type: Long/short equity, Event-driven
- Founders: Larry Robbins
- Key people: Larry Robbins (Chief Investment Officer); John Rodin (Chief Executive Officer); Jon Ansel (Portfolio Manager); Tim Soliman (Portfolio Manager); Mark Joseph Horowitz (President and General Counsel)
- Founded 2000 · HQ New York, US
- Reported AUM: $6.4bn (as of 2026-03-31)

### Approach
Glenview employs a bottom-up, fundamental research process focused on individual security selection. The firm utilizes a Growth at a Reasonable Price (GARP) style, often combined with contrarian, hidden value, or arbitrage strategies. Its investment team is structured by industry groups, and the firm frequently engages in Suggestivism, where it shares perspectives on long-term value creation with portfolio company management and boards.

### History
Glenview Capital Management was founded in 2000 by Larry Robbins after he left Omega Advisors. The firm is a New York-based investment management firm that manages capital for qualified investors through various private investment funds. Over its history, the firm has engaged in activist-style communications with portfolio companies, a practice it refers to as Suggestivism.

### Notable positions / campaigns
- Health Management Associates (HMA) (2013): Glenview objected to the merger terms and successfully pushed to replace the Board of Directors.
- Tenet Healthcare (2016): Glenview became the largest shareholder in the hospital chain.
- Dow Chemical / DowDuPont (2017): Glenview pushed for changes to the breakup plan of the combined company.
- Cigna / Express Scripts (2018): Glenview publicly supported the acquisition of Express Scripts by Cigna.

_Profile generated 2026-10-09 from public sources; may be incomplete or out of date._

## Rules
- Hold the top 20 long US-equity positions from the latest 13F-HR, weighted as reported.
- Rebalance on the first trading day after each new 13F-HR is filed. Cash only, paper only.

## Parameters
```json
{
  "params": {
    "funds": [
      "0001138995"
    ],
    "top_n": 20,
    "weighting": "13f",
    "rebalance": "filing_plus_1",
    "budget_usd": 10000,
    "stop_loss_pct": null,
    "cash_only": true
  }
}
```

> Estimated from 13F holdings (long US equities only; no shorts, options, cash or fees). Past performance is not a guide to the future. Not investment advice. Paper trading only.